AARTI DRUGS LTD. - 524348 - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2020
We wish to inform you that Board of Directors at its Meeting held on Friday, May 15, 2020, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2020. AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for To Consider, Approve And Take On Record Audited Financial Results For The Quarter And Year Ended March 31, 2020.
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2020 ,inter alia, to consider and approve This is to inform you that next Board Meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 15, 2020 to consider, approve and take on record Audited Financial Results for the Quarter and year ended March 31, 2020. AARTI DRUGS LTD. - 524348 - Compliance Certificate - Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2020 .
Compliance Certificate - Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March, 2020. AARTI DRUGS LTD. - 524348 - Compliance Of Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2020
We are forwarding herewith Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from Jagdish Patel & Co., Practicing Company Secretary, for the half year ended March 31, 2O20 for your perusal and record. AARTI DRUGS LTD. - 524348 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Aarti Drugs Ltd has submitted to BSE a copy of Clarification is enclosed. AARTI DRUGS LTD. - 524348 - Shareholding for the Period Ended March 31, 2020
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 AARTI DRUGS LTD. - 524348 - Clarification sought from Aarti Drugs Ltd
The Exchange has sought clarification from Aarti Drugs Ltd on April 13, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. AARTI DRUGS LTD. - 524348 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0321 Name of the Signatory :- RUSHIKESH DEOLEDesignation :- Company Secretary and Compliance Officer